API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. EVLO.PINK

Evelo Biosciences Inc (EVLO PINK) stock market data APIs

$0.0001 0(0%) as of September 9, 2024
Price chart is built with Anychart

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Evelo Biosciences Inc Financial Data Overview

0.0001
0.0001
-
0.0001
0.0001
0.0001-6.83
1 898
18 983 K
0
-0.7112
1.593
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVLO',
Type: 'Common Stock',
Name: 'Evelo Biosciences Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00H43XR69',
ISIN: NULL,
CUSIP: NULL,
CIK: '1694665',
EmployerIdNumber: '46-5594527',
FiscalYearEnd: 'December',
IPODate: '2018-05-09',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Evelo Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -69 674 000
  • Earnings Per Share -15.64
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Evelo Biosciences Inc Earnings via APIs

  • Latest Release 2023-11-09
  • EPS/Forecast -0.97

Get Evelo Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Evelo Biosciences Inc latest news via APIs

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Ea...

Q3 2023 Horizon Technology Finance Corp Earnings Call

Participants Daniel Raffaele Trolio; Executive VP, CFO & Treasurer; Horizon Technology Finance Corporation Gerald A. Michaud; President & Director; Horizon Technology Finance Corporation Megan N. B...
Do you have any questions?
support@eodhistoricaldata.com